The Latest Breaking News from Molina Healthcare

Michael Burry says he’s happy with MOH stock, even as Molina Healthcare stock crumbles 25% on disappointing guidance. But are MOH shares really worth buying today?

Molina Healthcare is expected to unveil its fourth-quarter results next month, and analysts expect a double-digit decrease in earnings.

Centene, which is a top participant in public health exchanges, jumped 8%, Molina Healthcare rallied 5%, and Oscar Health soared 24%.

After a year of clear underperformance, analysts are hitting pause and taking a more skeptical view of Molina Healthcare’s outlook.

(Editor’s note: The future prices of benchmark tracking ETFs, earnings, and the headline were updated in the story.)

Down over 60% from all-time highs, Molina Healthcare trades at a cheap multiple and has attracted the attention of Michael Burry.

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

The S&P 500 Index ($SPX ) (SPY ) on Thursday closed up +0.58%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.31%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.88%. December E-mini S&P futures (ESZ25 ) rose +0.58%, and December E-mini Nasdaq futures...

U.S. healthcare insurance providers Centene Corporation (NYSE:CNC) and Oscar Health Inc. (NYSE:OSCR) stock are trading lower as their peer Molina Healthcare Inc. (NYSE:MOH) reported disappointing annual guidance.